Project description
Oral drug absorption for the ageing population
Although the elderly population (>65 years old) is the group that suffers most from chronic disorders, they are paradoxically not considered in the drug development process, which only employs data from healthy adults aged 18–55. To address this limitation, the EU-funded AGePOP project will investigate the physiological gastrointestinal tract alterations associated with ageing and improve oral drug effectiveness. Through an interdisciplinary training programme, the project will help early-stage researchers study the characteristics of the gastrointestinal tract of older people and geriatric patients, thereby guiding the future development of drugs suitable for this age group.
Fields of science
Programme(s)
Funding Scheme
MSCA-ITN-ETN - European Training NetworksCoordinator
10561 Athina
Greece
See on map
Participants (5)
3000 Leuven
See on map
17489 Greifswald
See on map
51373 Leverkusen
See on map
64293 Darmstadt
See on map
4070 Basel
See on map